A detailed history of Norden Group LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Norden Group LLC holds 31,399 shares of CRL stock, worth $6.27 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
31,399
Previous 1,145 2642.27%
Holding current value
$6.27 Million
Previous $271 Million 3043.06%
% of portfolio
0.09%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$203.52 - $273.43 $6.02 Million - $8.08 Million
-29,563 Reduced 94.15%
1,836 $497 Million
Q1 2024

Apr 19, 2024

BUY
$203.52 - $273.43 $6.16 Million - $8.27 Million
30,254 Added 2642.27%
31,399 $8.51 Billion
Q4 2023

Feb 05, 2024

SELL
$164.52 - $238.84 $65,808 - $95,536
-400 Reduced 25.89%
1,145 $271 Million
Q3 2023

Nov 06, 2023

BUY
$194.44 - $217.61 $300,409 - $336,207
1,545 New
1,545 $303 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Norden Group LLC Portfolio

Follow Norden Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norden Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norden Group LLC with notifications on news.